Smallpox PEP: SIGA awarded DOD contract to develop TPOXX
by Press Release from Outbreak News Today on (#4JY66)
SIGA Technologies, Inc. (SIGA), a commercial-stage pharmaceutical company focused on the health security market, announced that it has been awarded a multi-year contract from the United States Department of Defense (DoD) to support work necessary to gain a potential label expansion for TPOXX(R) (tecovirimat) that would include Post-Exposure Prophylaxis (PEP) of smallpox. The contract is valued ["]
The post Smallpox PEP: SIGA awarded DOD contract to develop TPOXX appeared first on Outbreak News Today.